We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CECO icon
876
Ceco Environmental
CECO
$4.01B
$498K 0.01%
83,300
– –
KVHI icon
877
KVH Industries
KVHI
$162M
$496K 0.01%
56,974
– –
MNOV icon
878
MediciNova
MNOV
$66.9M
$494K 0.01%
195,147
-10,000
-5% -$26.1K
VNRX icon
879
VolitionRx Ltd
VNRX
$9.23M
$494K 0.01%
12,055
– –
PNBK icon
880
Patriot National Bancorp
PNBK
$134M
$493K 0.01%
40,500
+19,500
+93% +$286K
IRMD icon
881
iRadimed
IRMD
$1.17B
$489K 0.01%
14,400
-3,996
-22% -$143K
MLSS icon
882
Milestone Scientific
MLSS
$41.1M
$482K 0.01%
526,700
– –
KNDI
883
Kandi Technologies Group
KNDI
$70.3M
$480K 0.01%
200,000
– –
MXCT icon
884
MaxCyte
MXCT
$119M
$479K 0.01%
+101,200
New +$498K
RFIL icon
885
RF Industries
RFIL
$142M
$479K 0.01%
77,326
– –
CALB
886
DELISTED
California BanCorp Common Stock
CALB
$479K 0.01%
25,200
+7,500
+42% +$158K
BRLT icon
887
Brilliant Earth
BRLT
$19.7M
$477K 0.01%
+100,500
New +$631K
CMCL icon
888
Caledonia Mining Corp
CMCL
$392M
$476K 0.01%
43,435
+5,100
+13% +$69.6K
DSKE
889
DELISTED
Daseke, Inc. Common Stock
DSKE
$475K 0.01%
74,400
– –
UTRS
890
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$475K 0.01%
10,110
+6,365
+170% +$369K
GENC icon
891
Gencor Industries
GENC
$212M
$474K 0.01%
46,650
– –
DBTX
892
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$471K 0.01%
111,982
-2,946
-3% -$6.96K
RBKB icon
893
Rhinebeck Bancorp
RBKB
$196M
$470K 0.01%
50,000
– –
AFBI
894
DELISTED
Affinity Bancshares
AFBI
$468K 0.01%
31,500
+19,000
+152% +$284K
CLSD
895
DELISTED
Clearside Biomedical
CLSD
$465K 0.01%
21,107
– –
AREN icon
896
Arena Group
AREN
$75.2M
$461K 0.01%
+51,200
New +$547K
CHRA
897
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$459K 0.01%
12,270
– –
CHUY
898
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$458K 0.01%
23,000
-25,000
-52% -$574K
ACCS
899
ACCESS Newswire
ACCS
$26.1M
$456K 0.01%
17,900
– –
PZN
900
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$454K 0.01%
68,900
-15,500
-18% -$106K
34 35
36
37 38

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.